Advertisement
YOU ARE HERE: LAT HomeCollectionsTiclopidine Drug
IN THE NEWS

Ticlopidine Drug

FEATURED ARTICLES
CALIFORNIA | LOCAL
August 28, 1989 | From staff and wire reports and
An experimental drug narrowly outperforms aspirin in preventing strokes in high-risk patients, New York University researchers reported last week in the New England Journal of Medicine. The drug, ticlopidine, "was found to be somewhat more effective than aspirin in reducing the risk of death" in patients with early warning signs of stroke, the researchers said. Significantly, the drug was found to benefit women as well as men.
ARTICLES BY DATE
NATIONAL
June 11, 2003 | From Times Wire Reports
Aspirin was cheaper and more effective than the popular prescription drug ticlopidine at preventing stroke-producing blood clots from forming, a study of at-risk blacks said. The six-year study of 1,809 black men and women who previously suffered a stroke found 12% of those who took aspirin had a recurrent stroke, heart attack, or died from a vascular problem, compared with nearly 15% of those taking ticlopidine. The results, published in the Journal of the American Medical Assn.
Advertisement
NATIONAL
June 11, 2003 | From Times Wire Reports
Aspirin was cheaper and more effective than the popular prescription drug ticlopidine at preventing stroke-producing blood clots from forming, a study of at-risk blacks said. The six-year study of 1,809 black men and women who previously suffered a stroke found 12% of those who took aspirin had a recurrent stroke, heart attack, or died from a vascular problem, compared with nearly 15% of those taking ticlopidine. The results, published in the Journal of the American Medical Assn.
CALIFORNIA | LOCAL
August 28, 1989 | From staff and wire reports and
An experimental drug narrowly outperforms aspirin in preventing strokes in high-risk patients, New York University researchers reported last week in the New England Journal of Medicine. The drug, ticlopidine, "was found to be somewhat more effective than aspirin in reducing the risk of death" in patients with early warning signs of stroke, the researchers said. Significantly, the drug was found to benefit women as well as men.
Los Angeles Times Articles
|